JP2012130346A5 - - Google Patents

Download PDF

Info

Publication number
JP2012130346A5
JP2012130346A5 JP2012028159A JP2012028159A JP2012130346A5 JP 2012130346 A5 JP2012130346 A5 JP 2012130346A5 JP 2012028159 A JP2012028159 A JP 2012028159A JP 2012028159 A JP2012028159 A JP 2012028159A JP 2012130346 A5 JP2012130346 A5 JP 2012130346A5
Authority
JP
Japan
Prior art keywords
paramyxovirus
genomic rna
protein
complementary strand
ribozyme
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2012028159A
Other languages
English (en)
Japanese (ja)
Other versions
JP5438149B2 (ja
JP2012130346A (ja
Filing date
Publication date
Application filed filed Critical
Priority to JP2012028159A priority Critical patent/JP5438149B2/ja
Priority claimed from JP2012028159A external-priority patent/JP5438149B2/ja
Publication of JP2012130346A publication Critical patent/JP2012130346A/ja
Publication of JP2012130346A5 publication Critical patent/JP2012130346A5/ja
Application granted granted Critical
Publication of JP5438149B2 publication Critical patent/JP5438149B2/ja
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

JP2012028159A 2004-01-22 2012-02-13 サイトメガロウイルスエンハンサーおよびニワトリβ−アクチンプロモーターを含むハイブリッドプロモーターを利用したマイナス鎖ＲＮＡウイルスベクターの製造方法 Expired - Lifetime JP5438149B2 (ja)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2012028159A JP5438149B2 (ja) 2004-01-22 2012-02-13 サイトメガロウイルスエンハンサーおよびニワトリβ−アクチンプロモーターを含むハイブリッドプロモーターを利用したマイナス鎖ＲＮＡウイルスベクターの製造方法

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP2004014653 2004-01-22
JP2004014653 2004-01-22
JP2012028159A JP5438149B2 (ja) 2004-01-22 2012-02-13 サイトメガロウイルスエンハンサーおよびニワトリβ−アクチンプロモーターを含むハイブリッドプロモーターを利用したマイナス鎖ＲＮＡウイルスベクターの製造方法

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
JP2005517263A Division JP4999330B2 (ja) 2004-01-22 2005-01-20 サイトメガロウイルスエンハンサーおよびニワトリβ−アクチンプロモーターを含むハイブリッドプロモーターを利用したマイナス鎖ＲＮＡウイルスベクターの製造方法

Publications (3)

Publication Number Publication Date
JP2012130346A JP2012130346A (ja) 2012-07-12
JP2012130346A5 true JP2012130346A5 (enExample) 2013-04-25
JP5438149B2 JP5438149B2 (ja) 2014-03-12

Family

ID=34805423

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2005517263A Expired - Lifetime JP4999330B2 (ja) 2004-01-22 2005-01-20 サイトメガロウイルスエンハンサーおよびニワトリβ−アクチンプロモーターを含むハイブリッドプロモーターを利用したマイナス鎖ＲＮＡウイルスベクターの製造方法
JP2012028159A Expired - Lifetime JP5438149B2 (ja) 2004-01-22 2012-02-13 サイトメガロウイルスエンハンサーおよびニワトリβ−アクチンプロモーターを含むハイブリッドプロモーターを利用したマイナス鎖ＲＮＡウイルスベクターの製造方法

Family Applications Before (1)

Application Number Title Priority Date Filing Date
JP2005517263A Expired - Lifetime JP4999330B2 (ja) 2004-01-22 2005-01-20 サイトメガロウイルスエンハンサーおよびニワトリβ−アクチンプロモーターを含むハイブリッドプロモーターを利用したマイナス鎖ＲＮＡウイルスベクターの製造方法

Country Status (8)

Country Link
US (1) US8741650B2 (enExample)
EP (2) EP2434020B1 (enExample)
JP (2) JP4999330B2 (enExample)
KR (1) KR101279677B1 (enExample)
CN (1) CN1934260B (enExample)
AU (1) AU2005206410A1 (enExample)
CA (1) CA2553976C (enExample)
WO (1) WO2005071092A1 (enExample)

Families Citing this family (50)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2236378C (en) * 1995-11-01 2011-01-25 Dnavec Research Inc. Recombinant sendai virus
US20030166252A1 (en) * 1999-05-18 2003-09-04 Kaio Kitazato Paramyxovirus-derived RNP
US7402427B2 (en) * 2002-04-30 2008-07-22 Dnavec Research Inc. Vectors with modified protease-dependent tropism
KR101279748B1 (ko) * 2003-11-04 2013-07-04 가부시키가이샤 디나벡크 겐큐쇼 유전자 도입된 수상세포의 제조방법
EP1775343A4 (en) * 2004-06-24 2007-11-14 Dnavec Research Inc ANTITUM-AGENT WITH DENDRITIC CELL WITH THE TRANSFECTED RNA VIRUS
JP4969444B2 (ja) 2005-06-14 2012-07-04 ディナベック株式会社 抗体の作製方法
US20100167341A1 (en) * 2006-01-17 2010-07-01 Dnavec Corporation Novel protein expression system
WO2007139178A1 (ja) 2006-05-31 2007-12-06 Dnavec Corporation アルツハイマー病治療薬
CA2658266A1 (en) 2006-07-13 2008-01-17 Dnavec Corporation Non-replicating paramyxoviridae virus vector
KR100725023B1 (ko) * 2006-10-16 2007-06-07 제일모직주식회사 카도계 수지를 함유한 수지 조성물 및 그에 의한 패턴의 제조방법, 이를 이용한 컬러필터
KR20090114431A (ko) 2007-02-07 2009-11-03 디나벡크 가부시키가이샤 약독화 마이너스 가닥 ｒｎａ 바이러스
EP2143794A1 (en) 2007-04-27 2010-01-13 Kyushu University, National University Corporation Viral vector for gene therapy
WO2010008054A1 (ja) 2008-07-16 2010-01-21 ディナベック株式会社 染色体非組み込み型ウイルスベクターを用いてリプログラムされた細胞を製造する方法
JP5670330B2 (ja) 2008-08-07 2015-02-18 ハー マジェスティ ザ クイーン イン ライト オブ カナダ アズ リプリゼンテド バイ ザ ミニスター オブ ヘルスＨＥＲ ＭＡＪＥＳＴＹ ＴＨＥ ＱＵＥＥＮ ＩＮ ＲＩＧＨＴＯＦ ＣＡＮＡＤＡ ａｓ ｒｅｐｒｅｓｅｎｔｅｄ ｂｙ ＴＨＥ ＭＩＮＩＳＴＥＲ ＯＦ ＨＥＡＬＴＨ 最適化したプロモーター配列
US20120088819A1 (en) 2008-10-31 2012-04-12 Makoto Inoue Method for enhancing expression of recombinant protein
US9090909B2 (en) 2010-08-30 2015-07-28 Dnavec Corporation Composition for inducing pluripotent stem cell, and use thereof
CN102436142B (zh) 2010-09-29 2013-11-06 第一毛织株式会社 黑色光敏树脂组合物以及使用其的光阻层
KR101367253B1 (ko) 2010-10-13 2014-03-13 제일모직 주식회사 감광성 수지 조성물 및 이를 이용한 차광층
KR101038126B1 (ko) 2010-11-30 2011-05-31 주식회사 엘지생명과학 새로운 융합 프로모터 및 이를 포함하는 재조합 벡터
CN102028943A (zh) * 2010-12-08 2011-04-27 中国人民解放军军事医学科学院微生物流行病研究所 一种呼吸道合胞病毒样颗粒疫苗及其制备方法
KR101486560B1 (ko) 2010-12-10 2015-01-27 제일모직 주식회사 감광성 수지 조성물 및 이를 이용한 차광층
KR101453769B1 (ko) 2010-12-24 2014-10-22 제일모직 주식회사 감광성 수지 조성물 및 이를 이용한 컬러 필터
US20130325376A1 (en) 2011-04-07 2013-12-05 Thomas Edwin Turicchi, Jr. Systems and methods for determining a power phase and/or a phase rotation
KR101344786B1 (ko) 2011-12-02 2013-12-26 제일모직주식회사 컬러필터용 감광성 수지 조성물 및 이를 이용한　컬러필터
FR2986536A1 (fr) * 2012-02-08 2013-08-09 Lfb Biotechnologies Unites de transcription et leur utilisation dans des vecteurs d'expression (cho)
HUE026516T2 (en) 2012-09-24 2016-06-28 Lonza Biologics Plc Expression vectors containing chimeric cytomegalovirus promoter and enhancer sequences
KR20140076320A (ko) 2012-12-12 2014-06-20 제일모직주식회사 감광성 수지 조성물 및 이를 이용한 블랙 스페이서
US9828609B2 (en) 2013-03-12 2017-11-28 International Park Of Creativity Biological devices and methods for increasing the production of lycopene from plants
WO2015046229A1 (ja) 2013-09-24 2015-04-02 ディナベック株式会社 多能性幹細胞の誘導効率を改善する方法
PT3628334T (pt) 2014-03-21 2023-09-26 Genzyme Corp Terapia genética para retinopatia pigmentar
CN104404005A (zh) * 2014-12-22 2015-03-11 天津瑞普生物技术股份有限公司 禽流感病毒ha基因重组腺病毒的制备方法
WO2018092887A1 (ja) 2016-11-17 2018-05-24 国立感染症研究所長が代表する日本国 非感染性パラミクソウイルス粒子を用いた感染症ワクチン
US12359221B2 (en) 2017-05-05 2025-07-15 The Regents Of The University Of California Compositions and methods for expressing otoferlin
CN111479920B (zh) 2017-07-21 2025-08-01 株式会社爱医隆集团 用于修饰靶序列的多核苷酸及其用途
MX2020000993A (es) 2017-07-26 2020-07-22 Oncorus Inc Vectores virales oncolíticos y usos de estos.
EP3744847A4 (en) 2018-01-22 2021-12-08 Japan as Represented by The Director-General of National Institute of Infectious Diseases SELECTIVE CD8 POSITIVE T CELL INDUCING VACCINE ANTIGEN
WO2020093018A1 (en) 2018-11-01 2020-05-07 University Of Florida Research Foundation, Incorporated A codon optimized otoferlin aav dual vector gene therapy
EP3921032A4 (en) 2019-02-08 2022-11-30 Decibel Therapeutics, Inc. COMPOSITIONS AND METHODS FOR TREATMENT OF SENSORINEURAL HEARING LOSS USING OTOFERLIN DOUBLE VECTOR SYSTEMS
CN109929847B (zh) * 2019-02-27 2023-08-15 苏州系统医学研究所 一种pex26基因、蛋白及其应用
EP3988650A4 (en) * 2019-06-21 2022-09-21 Osaka University METHOD OF PRODUCING AN ARTIFICIAL RECOMBINANT RNA VIRUS THAT KEEPS A FOREIGN GENE STABLE
CN114765990A (zh) * 2019-10-10 2022-07-19 昂克诺斯公司 双重病毒和双重溶瘤病毒以及治疗方法
TWI896570B (zh) 2019-10-30 2025-09-11 美商迪賽博治療公司 使用耳畸蛋白雙載體系統治療感覺神經性聽力損失之組合物及方法
IL295741A (en) 2020-04-01 2022-10-01 Univ Florida Dual aav-myo7a vectors with improved safety for the treatment of ush1b
US20230220025A1 (en) 2020-09-04 2023-07-13 Heartseed Inc. Quality Improving Agent for IPS Cells, Method of Producing IPS Cells, IPS Cells, and Composition for Producing IPS Cells
US20240060051A1 (en) 2020-12-25 2024-02-22 Kyoto University Method for Producing Naive Human IPS Cells From Somatic Cells
US20240309335A1 (en) * 2021-06-30 2024-09-19 Repli-Tech Co., Ltd. Method of producing negative-strand rna virus vector and produced negative-strand rna virus vector
CN117535291A (zh) * 2021-09-08 2024-02-09 北京锦篮基因科技有限公司 一种高表达活性的组成型启动子及其应用
CN118475700A (zh) 2021-12-27 2024-08-09 礼富利科技股份有限公司 温度敏感性的负链rna病毒或病毒载体及其rna基因组
CN121057822A (zh) 2023-03-22 2025-12-02 礼富利科技股份有限公司 温度敏感性的负链rna病毒或病毒载体及其rna基因组
CN117051040B (zh) * 2023-08-15 2024-10-01 北京百普赛斯生物科技股份有限公司 Vsv△g复制缺陷型病毒制备及应用

Family Cites Families (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1339413C (en) * 1988-06-24 1997-09-02 Junichi Miyazaki Exogenous gene expression vector containing chick .beta.-actin gene promoter
JP2824434B2 (ja) 1989-11-28 1998-11-11 財団法人化学及血清療法研究所 新規発現ベクター
JP2001283451A (ja) 1992-05-13 2001-10-12 Matsushita Electric Ind Co Ltd 記録方法および再生方法
JPH06230752A (ja) 1992-09-14 1994-08-19 Hitachi Ltd 表示装置の駆動方法
JPH06230753A (ja) 1993-01-29 1994-08-19 Fuji Xerox Co Ltd 画像処理装置
JPH06233879A (ja) 1993-02-08 1994-08-23 Brother Ind Ltd ロックミシンのかがり方式変換装置
US5798100A (en) 1994-07-06 1998-08-25 Immunomedics, Inc. Multi-stage cascade boosting vaccine
WO1997016538A1 (en) 1995-10-31 1997-05-09 Dnavec Research Inc. (-)-strand rna virus vector having autonomously replicating activity
CA2236378C (en) * 1995-11-01 2011-01-25 Dnavec Research Inc. Recombinant sendai virus
KR100461701B1 (ko) 1996-02-29 2005-04-06 다카라 바이오 가부시키가이샤 바이러스의정제및제거방법
US6596529B1 (en) * 1997-05-02 2003-07-22 Uab Research Foundation Manipulation of negative stranded RNA viruses by rearrangement of their genes and uses thereof
PT1034262E (pt) 1997-11-18 2005-10-31 Pioneer Hi Bred Int Composicoes e metodos para a modificacao genetica de plantas
EP1106692B1 (en) 1998-08-11 2005-06-15 Dnavec Research Inc. Rna virus vector having contact infiltration capability
CN100352925C (zh) 1999-05-18 2007-12-05 株式会社载体研究所 副粘病毒衍生的rnp
US20030166252A1 (en) * 1999-05-18 2003-09-04 Kaio Kitazato Paramyxovirus-derived RNP
US20020169306A1 (en) * 1999-05-18 2002-11-14 Kaio Kitazato Envelope gene-deficient paramyxovirus vector
US20030022376A1 (en) * 1999-05-18 2003-01-30 Kaio Kitazato Paramyxovirus-derived RNP
WO2000070070A1 (en) * 1999-05-18 2000-11-23 Dnavec Research Inc. Paramyxoviridae virus vector defective in envelope gene
US7226786B2 (en) * 1999-05-18 2007-06-05 Dnavec Research Inc. Envelope gene-deficient Paramyxovirus vector
EP1067179A1 (en) 1999-07-09 2001-01-10 Pierre Fabre Medicament Method to select attenuated paramyxoviridae useful for vaccines and therapeutics
HK1047450A1 (zh) 1999-09-06 2003-02-21 株式会社载体研究所 含有已改变的转录起始序列的副粘病毒
JP4791651B2 (ja) 2000-05-18 2011-10-12 株式会社ディナベック研究所 外来遺伝子導入用パラミクソウイルスベクター
US20050130123A1 (en) 2001-09-18 2005-06-16 Makoto Inoue Methods of examining (-) strand rna virus vectors having lowered ability to form grains and method of constructing the same
US7402427B2 (en) * 2002-04-30 2008-07-22 Dnavec Research Inc. Vectors with modified protease-dependent tropism
EP1775343A4 (en) * 2004-06-24 2007-11-14 Dnavec Research Inc ANTITUM-AGENT WITH DENDRITIC CELL WITH THE TRANSFECTED RNA VIRUS
WO2006112553A2 (en) * 2005-04-20 2006-10-26 Dnavec Corporation Highly safe intranasally administrable gene vaccines for treating alzheimer's disease
WO2007139178A1 (ja) * 2006-05-31 2007-12-06 Dnavec Corporation アルツハイマー病治療薬

Similar Documents

Publication Publication Date Title
Jansson et al. MicroRNA and cancer
ZA202306380B (en) Rna-guided human genome engineering
WO2014039692A3 (en) Fad2 performance loci and corresponding target site specific binding proteins capable of inducing targeted breaks
NZ705745A (en) Fad3 performance loci and corresponding target site specific binding proteins capable of inducing targeted breaks
CA2553976A1 (en) Method for producing minus-strand rna viral vectors using hybrid promoter comprising cytomegalovirus enhancer and chicken .beta.-actin promoter
MX363017B (es) Métodos y productos para la expresión de proteínas en células.
JP2016528894A5 (enExample)
WO2014205192A3 (en) Targeted integration
WO2014059356A3 (en) Selective antisense compounds and uses thereof
WO2007002008A3 (en) Methods and compositions for expressing negative-sense viral rna in canine cells
WO2007124327A3 (en) Methods and compositions for expressing negative-sense viral rna in canine cells
WO2014022702A3 (en) Methods and compositions for controlling gene expression by rna processing
WO2011159836A3 (en) Compounds and methods for modulating interaction between proteins and target nucleic acids
MX382822B (es) Metodos y productos para transfeccion de celulas.
WO2014172470A3 (en) Methods of mutating, modifying or modulating nucleic acid in a cell or nonhuman mammal
JP2010512779A5 (enExample)
WO2012074277A3 (en) Novel hybrid promoter and recombinant vector comprising the same
HK1204003A1 (zh) 用於rna定向的目标dna修饰和rna定向的转录调控的方法和组合物
WO2012115454A3 (ko) 뉴클레아제에 의해 유전자 변형된 세포를 농축시키는 방법
EA201492202A1 (ru) Способ экспрессии гетерологичных белков с использованием рекомбинантного вирусного вектора с минус-нитью рнк
WO2013049121A3 (en) Recombinant phage and methods
NZ612603A (en) Virus like particle production in plants
WO2013052908A3 (en) Nucleic acid molecules that target rps6 and confer resistance to coleopteran pests
WO2010128024A3 (en) Reversibly immortalized cells as well as methods relating hereto
HK1213294A1 (zh) 穩定的非多腺苷酸化rna的產生